Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children

Neuromuscular Disorders

Volumn 10, Issue 2, 2000, Pages 113-120

  Decary, S ^a   Ben Hamida, C ^b   Mouly, V ^a   Barbet, J P ^c   Hentati, F ^b   Butler Browne, G S ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Institut National de Neurologie Tunisia   (Tunisia)

^c Service d'Anatomie Pathologique   (France)

Author keywords

DMD; Human; LGMD 2C; Regeneration; Skeletal muscle; Telomeres

Indexed keywords

ADOLESCENT; ARTICLE; CELL DIVISION; CHILD; CHROMOSOME SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE BIOPSY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; SATELLITE CELL; SENESCENCE; TELOMERE;

ADOLESCENT; CELL AGING; CELL DIVISION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; REGENERATION; TELOMERE;

EID: 0033958440     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(99)00093-0     Document Type: Article

References (38)

1. Duchenne G.B. Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myo-sclérotique. Arch Gen Med. 11:1868;569-571.
2. Walton J.N., Nattras P.J. On the classification, natural history and treatment of the myopathies. Brain. 77:1954;169-231.
3. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne Muscular Dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 50:1987;509-517.
4. Koenig M., Monaco A.P., Kunkel L.M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 53:1988;219-226.
5. Suzuki A., Yoshida M., Hayashi K., Mizuno Y., Hagiwara Y., Ozawa E. Molecular organization at the glycoprotein-complex binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem. 220:1994;283-292.
6. Suzuki A., Yoshida M., Ozawa E. Mammalian alpha 1- and beta 1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus. J Cell Biol. 128:1995;373-381.
7. Ozawa E., Yoshida M., Suzuki A., Mizuno Y., Hagiwara Y., Noguchi S. Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet. 4:1995;1711-1716.
8. Beckmann J.S., Bushby K.M.D. Advances in the molecular genetics of the limb-girdle type of autosomal recessive progressive muscular dystrophy. Curr Opin Neurol. 9:1996;389-393.
9. Crosbie R.H., Heighway J., Venzke D.P., Lee J.C., Campbell K.P. Sarcospan, the 25 kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem. 272:1997;31221-31224.
10. Moreira E.S., Vainzof J.M., Marie S.K., et al. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet. 61:1997;151-159.
11. Weiler T., Greenberg C.R., Zelinsky T., et al. A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus. Am J Hum Genet. 63:1998;140-147.
12. Speer M.C., Vance J.M., Grubber J.M., et al. Identification of a new autosomal dominant limb-girdle muscular dystrophy on chromosome 7. Am J Hum Genet. 64:1999;556-562.
13. Ben Hamida M., Fardeau M., Attia N. Severe childhood muscular dystrophy affecting both sexes and frequent in Tunisia. Muscle Nerve. 6:1983;469-480.
14. Ben Othmane K., Ben Hamida M., Pericak-Vance M.A., et al. Linkage of Tunisian autosomal recessive Duchenne like muscular dystrophy to the pericentromeric region of chromosome 13q. Nat Genet. 2:1992;315-317.
15. Noguchi S., McNally E.M., Ben Othmane K., et al. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science. 270:1995;819-822.
16. Vainzof M., Passos-Bueno M.R., Canovas M., et al. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet. 5:1996;1963-1969.
17. Ervasti J.M., Ohlendieck K., Kahl S.D., Gaver M.G., Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 345:1990;315-319.
18. Matsumura K., Tomé F.M.S., Ionasesce V., et al. Deficiency of dystrophin associated-protein in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. J Clin Invest. 92:1993;866-871.
19. Mizuno Y., Yoshida M., Nonaka I., Hirai S., Ozawa E. Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve. 17:1994;206-216.
20. Pasternak C., Wong S., Elson E.L. Mechanical function of dystrophin in muscle cells. J Cell Biol. 128:1995;355-361.
21. Holt K.H., Campbell K.P. Assembly of the sarcoglycan complex. insights for muscular dystrophy. J Biol Chem. 273:1998;34667-34670.
22. Engel A.G., Yamamoto M., Fischbeck K.H. Dystrophinopathies. Engel A.E., Franzini-Armstrong C. Myology. 1994;1133-1187 McGraw-Hill, New York.
23. Decary S., Mouly V., Ben Hamida C., Sautet A., Barbet J.P., Butler-Browne G.S. Replicative potential and telomere length in human skeletal muscle: Implications for satellite cell-mediated gene therapy. Hum Gene Ther. 8:1997;1429-1438.
24. Harley C.B., Villeponteau B. Telomeres and telomerase in aging and cancer. Cur Opin Genet Dev. 5:1995;249-255.
25. Bodnar A.G., Ouellette M., Frolkis M., et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
26. Decary S., Mouly V., Butler-Browne G.S. Telomere length as a toll to monitor satellite cell amplification for cell-mediated gene therapy. Hum Gene Ther. 7:1996;1347-1350.
27. Lindsey J., McGill N.I., Lindsey L.A., Green D.K., Cooke H.J. In vivo loss of telomeric repeats with age in humans. Mut Res. 256:1991;45-48.
28. Vaziri H., Schächter F., Uchida I., et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 52:1993;661-667.
29. Marini J.F., Pons F., Leger J., et al. Expression of myosin heavy chain isoforms in Duchenne muscular dystrophy patients and carriers. Neuromusc Dis ord. 1:1991;397-409.
30. Dubowitz V. Muscle disorders in childhood. 1995;W.B Saunders. pp. 31.
31. Allsopp R.C., Vaziri H., Patterson C., et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 89:1992;10114-10118.
32. Barbet J.P., Thornell L.E., Butler-Browne G.S. Immunocytochemical characterization of two generations of fibers during the development of the human quadriceps muscle. Mech Dev. 35:1991;3-11.
33. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 346:1990;866-868.
34. Schmalbruch H., Hellhamer U. The number of satellite cells in normal human muscle. Anat Rec. 185:1976;279-288.
35. Kitada T., Seki S., Kawakita N., Kuroki T., Monna T. Telomere shortening in chronic liver diseases. Biochem Biophys Res Commun. 211:1995;33-39.
36. Pommier J.P., Gauthier L., Livartowski J., et al. Immunosenescence in HIV pathogenesis. Virology. 231:1997;148-154.
37. Bell C.D., Conen P.E. Histolopathologic changes in Duchenne muscular dystrophy. J Neurol Sci. 7:1968;529-544.
38. Webster C., Blau H.M. Accelerated age-related decline in replicative life-span of duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy. Som Cell Mol Genet. 16:1990;557-565.